mesenchym
stem
cell
msc
show
promis
therapeut
recoveri
function
damag
myocardium
msc
home
injur
tissu
contribut
structur
function
recoveri
myocardium
via
secret
paracrin
factor
inhibit
immun
respons
andor
facilit
angiogenesi
transdifferentiationmetaplasia
nuclear
reprogram
fusion
resid
cardiomyocyt
cm
latter
larg
dismiss
sinc
frequenc
fusion
detect
low
rel
number
transplant
msc
howev
recent
studi
us
other
suggest
despit
low
frequenc
cell
fusion
still
may
exert
dramat
impact
stem
cell
program
reprogram
heart
cell
fate
determin
thought
unidirect
progenitor
cell
differenti
progress
perman
inactiv
specif
gene
allow
potenc
howev
technolog
advanc
suggest
strictli
case
pioneer
experi
nuclear
reprogram
util
cell
fusion
demonstr
cytoplasm
element
one
fusion
partner
impact
nuclear
transcript
factor
fusion
partner
induc
program
reprogram
later
studi
pinpoint
specif
transcript
factor
activ
exogen
fulli
reprogram
somat
cell
embryoniclik
state
though
success
reprogram
realiz
tailor
vitro
approach
program
may
requir
greater
tempor
control
spontan
physiolog
cellcel
fusion
tempor
spatial
regul
process
essenti
program
differenti
certain
cell
type
thu
cell
fusion
may
also
confer
regul
transfer
transcript
control
necessari
drive
stem
cell
progenitor
cell
differenti
repair
tissu
matur
anim
cellcel
fusion
occur
plasma
membran
neighbor
cell
fuse
form
multinucl
cell
fuse
lipid
bilay
cell
membran
must
come
close
contact
rang
sever
angstrom
achiev
degre
close
proxim
two
surfac
must
becom
least
partial
dehydr
water
bound
membran
enhanc
polar
repuls
membran
next
one
bilay
must
destabil
way
induc
local
rearrang
bilay
bilay
destabil
aqueou
bridg
form
cytoplasm
content
cell
mix
destabil
membran
occur
result
physic
stress
eg
electrofus
chemic
interfer
eg
polyethylen
glycol
electrofus
util
short
puls
electr
mechan
disrupt
lipid
bilay
cell
form
pore
two
disrupt
membran
come
contact
cell
fusion
may
occur
unfortun
process
toxic
cell
must
contact
one
anoth
time
electr
field
administ
laser
trap
prior
electrofus
use
effect
posit
fusion
partner
howev
process
low
throughput
cytotox
less
toxic
also
less
effect
less
reproduc
approach
use
polyethylen
glycol
peg
exact
mechan
peginduc
fusion
unknown
theoriz
due
either
local
dehydr
lead
unfavor
molecular
pack
bilay
dehydr
water
shell
near
lipid
bilay
caus
water
molecul
cell
displac
therebi
forc
two
membran
togeth
subsequ
fuse
cell
techniqu
proven
use
fusion
occur
time
administr
peg
thu
cell
deliveri
peg
would
induc
fusion
immedi
nonselect
mechan
would
better
regul
fusion
either
specif
cell
specif
region
within
tissu
necessari
studi
fusion
vivo
natur
destabil
cell
membran
subsequ
membran
fusion
util
activ
specif
integr
membran
protein
term
fusogen
primari
sourc
inform
fusogen
architectur
receptor
bind
activ
virus
extens
character
fusogen
influenza
hemagglutinin
ha
human
immunodefici
viru
type
envelop
protein
env
fusion
peptid
hydrophob
requir
proteolyt
cleavag
ha
activ
acid
ph
endocytosi
env
fuse
neutral
ph
review
less
wellstudi
fusogen
requir
eukaryot
cell
fusion
fusion
osteoclast
myoblast
trophoblast
greatest
challeng
establish
protein
true
fusogen
protein
facilit
fusion
place
cell
close
proxim
mani
put
fusogen
shown
support
protein
ie
essenti
adhes
migrat
identif
true
fusogen
difficult
group
propos
rank
scheme
clarifi
natur
function
protein
put
fusogen
spontan
stem
cell
fusion
identifi
develop
altern
strategi
direct
stem
cell
fusion
could
augment
understand
biolog
impact
fusion
util
viral
machineri
vesicular
stomat
viru
glycoprotein
vsvg
rhabdovirida
famili
induc
heterotyp
fusion
human
msc
mous
cm
vitro
vivo
mous
model
myocardi
infarct
follow
msccm
fusion
track
phenotyp
morpholog
fusion
product
one
week
vitro
week
vivo
vsvg
select
requir
proteolyt
cleavag
sole
mediat
receptor
bind
fusion
ph
depend
particular
vsvg
requir
facilit
protein
either
dock
host
membran
prior
fusion
enzym
prompt
activ
fusogen
furthermor
ph
depend
vsvg
advantag
local
heart
ph
acut
ischem
injuri
within
acid
rang
need
initi
conform
chang
vsvg
way
select
activ
vsvg
transfect
msc
vmsc
site
myocardi
injuri
induc
local
fusion
situ
therebi
increas
donor
cell
engraft
integr
within
tissu
potenti
facilit
cardiac
differenti
msc
deriv
human
embryon
stem
cell
msc
gift
dr
peiman
hematti
cardiomyocyt
gift
dr
william
claycomb
expand
cultur
previous
describ
briefli
msc
cultur
gelatin
sigmaaldrich
st
loui
mo
usa
pretreat
flask
contain
essenti
medium
mem
complet
alphamemcomplet
consist
invitrogen
carlsbad
ca
usa
fetal
bovin
serum
hyclon
logan
ut
mm
nonessenti
amino
acid
invitrogen
mm
lglutamin
invitrogen
msc
cultur
allow
grow
confluenc
replat
concentr
cm
cultur
fibronectingelatin
mg
ml
gelatin
sigmaaldrich
pretreat
flask
contain
claycombcomplet
claycombcomplet
medium
compris
claycomb
medium
safc
bioscienc
st
loui
mo
usa
fetal
bovin
serum
qualifi
cm
safc
bioscienc
uml
penicillinstreptomycin
lonza
walkersvil
md
usa
mm
norepinephrin
sigmaaldrich
mm
lglutamin
invitrogen
cm
passag
confluenc
split
experi
perform
use
passag
msc
cm
respect
cultur
maintain
msc
transfect
plasmid
encod
vsvg
cag
promot
use
neon
transfect
system
invitrogen
accord
manufactur
protocol
briefli
cell
transfect
plasmid
one
v
puls
msec
plate
plate
determin
transfect
effici
electropor
cell
cultur
h
immunocytochemistri
icc
perform
detect
vsvg
protein
express
briefli
cell
wash
two
rins
two
incub
pb
cell
fixat
perform
pfa
follow
anoth
set
wash
probe
dilut
fitcconjug
antivsvg
antibodi
genetex
san
antonio
tx
usa
bsa
min
cultur
wash
final
time
mount
dabcodapi
mount
medium
octan
sigmaaldrich
glycerol
fisher
scientif
forest
lawn
nj
usa
sigmaaldrich
pb
transfect
effici
calcul
number
cell
posit
vsvg
green
divid
total
number
cell
determin
cell
dissoci
reagent
alter
vsvg
express
duplic
vsvg
transfect
msc
vmsc
cultur
harvest
trypsin
mediatech
inc
manassa
va
usa
accutas
innov
cell
technolog
inc
san
diego
ca
usa
contain
mm
edta
inactiv
cultur
medium
wash
pb
probe
antivsvg
antibodi
wash
final
time
pb
vmsc
analyz
via
facscalibur
bd
bioscienc
san
jose
ca
usa
univers
wisconsin
carbon
cancer
center
flow
cytometri
facil
uwccc
vsvg
express
level
per
cell
determin
use
quantum
mesf
kit
molecul
equival
solubl
fluorochrom
bang
laboratori
inc
fisher
facscalibur
cytomet
bd
bioscienc
quantum
mesf
kit
consist
popul
microspher
increas
surfacelabel
fluorochrom
standard
specif
concentr
pure
fluorophor
per
microspher
popul
analyz
via
flow
cytometri
standard
curv
gener
plot
popul
ie
concentr
fluorophor
per
microspher
versu
intens
quickcal
softwar
use
verifi
linear
standard
curv
next
vmsc
correspond
control
popul
label
antivsvgfitc
antibodi
analyz
via
flow
cytometri
use
standard
curv
measur
intens
valu
vmsc
popul
correspond
control
number
fluorophor
per
cell
determin
valu
divid
averag
number
fluorophor
bind
singl
antigen
determin
number
protein
express
per
cell
ten
thousand
cell
three
replic
analyz
per
popul
popul
includ
vmsc
antivsvg
antibodi
msc
antivsvg
antibodi
vmsc
without
antibodi
determin
vmsc
fuse
readili
cardiomyocyt
untreat
msc
vmsc
msc
control
cocultur
cm
analyz
incid
fusion
distinguish
cell
type
cocultur
msc
cm
stain
celltrack
green
cmfda
red
cmtpx
molecular
probe
eugen
usa
respect
accord
manufactur
protocol
follow
label
cm
plate
cultur
h
follow
addit
msc
vmsc
per
well
plate
bd
bioscienc
h
cocultur
suspens
wash
pb
bath
min
fusion
media
vari
ph
ie
ph
correspond
activ
inact
form
vsvg
fusion
protein
adjust
hcl
longterm
character
fusion
product
medium
chang
day
day
cocultur
cocultur
cm
msc
vmsc
maintain
cultur
medium
h
incub
fusion
medium
follow
imag
flow
cytometri
imag
acquir
uplanfluor
object
na
fitc
texa
red
filter
invert
deconvolut
fluoresc
microscop
olympu
center
valley
pa
usa
analyz
slidebook
softwar
intellig
imag
innov
denver
co
usa
imagej
fiji
open
sourc
softwar
http
pacificmpicbgdewikiindexphpfiji
imag
normal
use
unstain
control
cell
analyz
uwccc
flow
cytometri
facil
facscalibur
flow
cytomet
bd
bioscienc
event
livedead
gate
forward
scatter
side
scatter
plot
fusion
product
quantifi
gate
region
posit
channel
correspond
celltrack
green
cmfda
red
cmtpx
respect
msc
cm
monolay
stain
protein
characterist
msc
well
protein
characterist
cm
sarcomer
myosin
cell
cultur
fix
paraformaldehyd
min
follow
two
wash
phosphat
buffer
salin
fisher
scientif
cell
probe
goat
santa
cruz
biotech
santa
cruz
ca
usa
rabbit
abgent
san
diego
ca
usa
goat
r
system
minneapoli
mn
usa
mous
development
studi
hybridoma
bank
iowa
citi
ia
dilut
dilut
respect
dilut
buffer
bsa
fisher
scientif
acro
organ
phosphat
buffer
salin
fisher
scientif
incub
min
room
temperatur
overnight
follow
incub
fluoresc
secondari
antibodi
donkey
antigoat
alexa
fluor
invitrogen
goat
antirabbit
alexa
fluor
invitrogen
donkey
antimous
invitrogen
dilut
preadsorpt
solut
dilut
buffer
human
serum
pelfreez
brown
deer
wi
usa
mous
serum
equitechbio
inc
kerrvil
tx
usa
min
room
temperatur
sampl
counterstain
dabcodapi
mount
solut
fluoresc
emiss
detect
invert
deconvolut
fluoresc
microscop
olympu
imag
acquir
uplanfluor
object
na
analyz
use
slidebook
softwar
intellig
imag
innov
denver
co
usa
imagej
fiji
open
sourc
softwar
http
pacificmpicbgdewikiindexphpfiji
imag
threshold
secondari
antibodi
control
valid
method
shown
supplementari
figur
avail
onlin
msccm
vmsccm
cocultur
probe
antibodi
cm
marker
msc
marker
evalu
morpholog
fusion
product
phenotyp
cell
within
cocultur
posit
event
fusion
calcul
percentag
posit
cell
contain
nucleu
divid
total
number
nuclei
obtain
analysi
least
eight
optic
field
per
sampl
field
field
select
base
cell
number
minimum
cell
posit
within
well
center
well
n
myocardi
infarct
induc
mice
jackson
laboratori
bar
harbor
usa
left
coronari
arteri
ligat
previous
describ
routin
perform
univers
wisconsin
cardiovascular
physiolog
core
facil
anim
procedur
perform
accord
guidelin
american
associ
laboratori
anim
scienc
univers
wisconsinmadison
anim
care
use
committe
tissuemend
tei
bioscienc
prepar
cell
seed
previous
describ
briefli
tissuemend
matric
mm
mm
mm
place
well
plate
contain
cultur
medium
follow
electropor
vmsc
seed
tissuemend
section
concentr
time
greater
msc
cell
control
due
cell
viabil
electropor
yield
cellsml
medium
chang
h
point
tissuemend
matrix
contain
msc
vmsc
unseed
matrix
control
tack
myocardium
corner
matrix
matrix
place
contact
infarct
periinfarct
region
myocardium
murin
heart
harvest
three
week
matrix
implant
assess
occurr
detect
frequenc
vivo
fusion
heart
bisect
longitudin
matrix
tissu
immedi
place
buffer
formalin
ph
fisher
scientif
h
follow
h
fresh
buffer
formalin
final
h
ethanol
sampl
process
paraffin
embed
section
previous
describ
fluoresc
situ
hybrid
fish
tissu
digest
kit
human
centromer
probe
red
mous
centromer
probe
green
kreatech
amsterdam
netherland
perform
section
detect
fusion
event
sampl
process
cytogenet
laboratori
wicel
research
institut
madison
wi
usa
accord
manufactur
protocol
briefli
slide
paraffin
embed
section
bake
h
specimen
incub
pepsin
min
tissu
digest
prior
sequenti
hybrid
human
probe
follow
mous
probe
imag
acquir
uplansapo
na
oil
dapi
green
orang
filter
olympu
upright
fluoresc
microscop
olympu
valley
pa
usa
analyz
fishview
version
softwar
appli
spectral
imag
vista
ca
fusion
event
defin
nuclei
posit
stain
human
centromer
red
mous
centromer
green
frequenc
fusion
event
report
number
fusion
event
per
total
nuclei
given
region
heart
tissu
myocardium
myo
myocardi
infarct
mi
border
region
border
within
tissuemend
patch
tm
healthi
myocardium
healthi
five
twelv
field
select
locat
number
heart
analyz
n
tm
n
tm
vmsc
comparison
vsvg
express
fusion
frequenc
fusion
product
morpholog
versu
control
normal
distribut
assum
oneway
analys
varianc
student
ttest
use
data
analyz
microsoft
excel
microsoft
redmond
wa
usa
msc
induc
express
vsvg
via
transfect
electropor
low
transfect
effici
would
limit
abil
vsvg
promot
fusion
vsvg
express
msc
determin
follow
electropor
twentyfour
hour
transfect
control
msc
msc
transfect
vsvg
vmsc
probe
antivsvg
antibodi
conjug
fluorescein
isothiocyan
fitc
visual
fluoresc
microscopi
determin
percentag
cell
express
vsvg
averag
transfect
effici
n
least
optic
field
per
sampl
per
trial
trial
figur
sinc
vmsc
harvest
vivo
studi
also
assess
vsvg
express
via
flow
cytometri
remov
cultur
plate
trypsin
found
express
vsvg
plummet
n
replic
per
sampl
per
trial
trial
figur
b
perhap
surpris
other
report
decreas
stabil
vsvg
trypsin
treatment
trypsin
serin
proteas
cleav
carboxyl
group
cell
surfac
remov
cell
cultur
surfac
vsvg
cell
surfac
protein
would
expos
dissoci
reagent
disrupt
vsvg
trypsin
corrobor
evalu
number
vsvg
protein
per
cell
administr
trypsin
significantli
reduc
number
vsvg
protein
cell
surfac
vmsc
figur
thu
replac
trypsin
accutas
mixtur
proteas
collagenas
shown
improv
cell
viabil
compar
trypsin
accutas
treatment
averag
number
cell
express
vsvg
cell
harvest
signific
improv
treatment
trypsin
level
high
enough
discern
whether
express
vsvg
impact
msccm
fusion
n
replic
per
sampl
per
trial
trial
fusogen
vsvg
potent
cell
surfac
adequ
amount
protein
facilit
fusion
low
enough
amount
avoid
immun
respons
thu
vsvg
protein
express
per
cell
determin
use
quantum
mesf
kit
bang
laboratori
inc
facscalibur
use
method
averag
number
vsvg
protein
per
cell
trypsin
accutas
n
replic
per
sampl
per
trial
trial
figur
c
thu
experi
perform
use
accutas
dissoci
reagent
prevent
vsvg
cleavag
determin
whether
msc
express
vsvg
better
equip
fuse
cm
unmanipul
counterpart
vmsc
msc
cocultur
cm
distinguish
cell
type
cocultur
msc
vmsc
stain
red
celltrack
cm
stain
green
celltrack
fluoresc
probe
prior
combin
sinc
vsvg
undergo
conform
chang
inact
form
activ
form
ph
cocultur
briefli
incub
min
fusion
medium
ph
imag
analysi
vmsccm
cocultur
treat
fusion
medium
ph
reveal
cell
coloc
green
red
fluoresc
indic
fusion
event
msccm
cocultur
ph
condit
exhibit
limit
coloc
figur
accur
assess
amount
cell
fusion
cocultur
harvest
hour
seed
analyz
via
flow
cytometri
doubl
posit
cell
correspond
fusion
event
vmsc
treat
acid
medium
ph
significantli
higher
rate
fusion
cm
msc
treat
way
ie
spontan
fusion
p
figur
b
percentag
fusion
product
identifi
vmsccm
cocultur
expos
fusion
medium
ph
maintain
vsvg
inact
form
differ
msccm
cultur
n
replic
per
sampl
per
trial
trial
figur
c
mani
studi
demonstr
stem
cell
program
influenc
microenviron
determin
whether
phenotyp
fate
vmsccm
fusion
product
could
regul
microenviron
follow
treatment
fusion
media
cultur
vmsccm
fusion
product
either
mscspecif
cmspecif
cultur
condit
examin
incid
fusion
morpholog
msccm
fusion
product
day
follow
induct
cell
fusion
cocultur
probe
cm
msc
specif
antibodi
respect
n
replic
per
sampl
per
trial
trial
day
vmsccm
cocultur
contain
rel
high
number
cell
express
percentag
cell
rel
total
cell
number
significantli
greater
msccm
cocultur
cultur
condit
p
figur
note
percentag
cell
much
higher
percentag
doubl
posit
cell
detect
use
celltrack
dye
flow
cytometri
figur
b
could
reflect
loss
vsvg
sustain
cell
harvest
differ
analyt
approach
ie
flow
cytometri
versu
imag
analysi
andor
behavior
fusion
product
day
day
ie
prolifer
day
percentag
cell
decreas
level
statist
differ
control
cultur
condit
time
number
cell
express
alon
increas
substanti
cultur
condit
chang
percentag
cell
day
day
could
reflect
death
fusion
product
program
msc
fusion
partner
cardiomyocyt
phenotyp
death
fusion
product
occur
one
would
expect
unfus
cm
msc
prolifer
fill
void
cultur
space
interestingli
cm
popul
increas
day
day
rate
significantli
higher
control
cultur
suggest
least
portion
fusion
product
maintain
ultim
adopt
cardiomyocytelik
phenotyp
result
observ
independ
cultur
condit
note
experiment
approach
exclud
possibl
metaplasia
rather
fusion
occur
msc
differenti
cm
consequ
solubl
factor
cocultur
medium
maintain
least
transient
express
cell
type
howev
cell
rare
msccm
cocultur
suggest
metaplasia
alon
account
coexpress
subsequ
loss
cell
addit
cell
exhibit
two
distinct
morpholog
long
spread
display
msclike
morpholog
msc
medium
cm
medium
major
p
round
cobblestonelik
indic
cmlike
morpholog
msc
medium
cm
medium
figur
b
c
supplementari
figur
result
support
possibl
cm
nuclear
materi
cytoplasm
element
direct
program
msccm
fusion
product
independ
cultur
condit
determin
whether
msc
express
vsvg
could
fuse
cardiac
cell
type
vivo
vmsc
deliv
damag
myocardium
via
tissuemend
patch
previous
demonstr
msc
deliv
way
maintain
patch
tissu
patch
myocardium
week
deliveri
higher
percentag
convent
deliveri
modal
furthermor
laflamm
et
al
found
one
major
factor
cell
loss
transplant
anoiki
thu
provid
anchorag
support
transplant
cell
increas
viabil
retent
studi
sought
determin
whether
vsvg
express
msc
donor
would
abl
migrat
damag
myocardium
fuse
recipi
cardiac
cell
type
thu
one
day
follow
induct
infarct
via
ligat
left
anterior
descend
arteri
patch
contain
vmsc
appli
heart
contact
healthi
damag
tissu
three
week
cell
transplant
heart
excis
histolog
perform
left
ventricular
tissu
previous
report
histolog
section
probe
use
fish
humanspecif
mousespecif
centromer
nuclei
contain
probe
consid
fusion
product
human
cell
found
tissuemend
patch
border
region
area
patch
myocardium
donorhost
cell
fusion
evid
tissuemend
patch
border
zone
infarct
myocardium
heart
receiv
tissuemend
vmsc
human
cell
fusion
product
found
healthi
cardiac
tissu
heart
receiv
tissuemend
vmsc
addit
human
cell
fusion
product
found
tissuemend
patch
border
zone
infarct
myocardium
heart
receiv
tissuemend
region
heart
receiv
tissuemend
vmsc
select
high
densiti
fusion
event
frequenc
cell
fusion
rel
total
number
nuclei
given
region
tissuemend
patch
n
heart
field
border
zone
n
heart
field
infarct
myocardium
n
heart
field
though
level
repres
maximum
amount
fusion
per
region
substanti
higher
previous
report
spontan
fusion
follow
msc
transplant
wherein
one
fusion
event
per
field
imag
contain
hundr
nuclei
rare
figur
result
demonstr
express
viral
fusogen
vsvg
use
induc
fusion
msc
potenti
clinic
relev
cell
type
enabl
studi
biolog
therapeut
impact
cell
fusion
heart
fusion
transplant
stem
cell
recipi
cardiomyocyt
observ
murin
porcin
model
system
sinc
first
observ
sought
unravel
mechan
govern
stem
cell
fusion
studi
implic
cell
fusion
stem
cell
program
lack
studi
reflect
overwhelm
opinion
cell
fusion
occur
infrequ
relev
stem
cell
program
corollari
tissu
repair
howev
opinion
fail
appreci
possibl
detect
methodolog
may
insuffici
accur
gaug
contribut
cell
fusion
follow
stem
cell
transplant
andor
might
abl
control
increas
frequenc
cell
fusion
effect
induc
program
stem
cell
follow
transplant
begun
explor
second
possibl
coopt
welldescrib
fusion
machineri
virus
find
mesenchym
stem
cell
modifi
express
viral
fusogen
vsvg
apt
fuse
cardiomyocyt
phdepend
manner
vmsccm
fusion
product
form
way
prone
adopt
cardiomyocyt
phenotyp
morpholog
addit
vmsc
deliv
myocardium
mice
follow
infarct
fuse
resid
cardiac
cell
type
rate
much
higher
previou
report
spontan
fusion
apt
fuse
site
infarct
healthi
myocardium
increas
frequenc
msccm
cell
fusion
aid
studi
cell
fusion
vitro
may
improv
therapeut
benefit
msc
vivo
one
way
therapeut
benefit
may
improv
via
induct
program
msc
cardiomyocyt
fate
differenti
msc
cm
initi
vitro
via
solubl
factor
includ
exposur
insolubl
factor
includ
laminin
howev
function
differenti
msc
cardiomyocyt
accomplish
date
via
cell
fusion
matur
cardiomyocyt
result
demonstr
vitro
vivo
wherein
msccm
fusion
product
take
cardiomyocyt
morpholog
express
cardiomyocyt
marker
coupl
adjac
cardiomyocyt
find
msccm
fusion
induc
viral
fusogen
cm
fusion
partner
domin
major
fusion
product
regardless
medium
type
adopt
cmlike
morpholog
maintain
express
lose
data
support
excit
possibl
induct
fusion
viral
fusogen
could
enhanc
msc
program
cm
fate
vivo
note
cm
util
cm
cell
line
use
enabl
largescal
longterm
studi
howev
heterogen
immort
natur
cell
may
account
seem
domin
cm
phenotyp
futur
studi
util
primari
fetal
cardiomyocyt
induc
pluripot
stem
cellderiv
cardiomyocyt
result
suggest
differenti
msc
cm
fate
promot
cellcel
fusion
howev
certain
circumst
vitro
msccm
fusion
product
reenter
cell
cycl
prolifer
suggest
cellcel
fusion
also
promot
reprogram
cm
prolifer
fusion
product
may
advantag
cardiac
tissu
repair
differenti
function
cell
type
sinc
cell
could
produc
replac
lost
cell
addit
recent
evid
demonstr
msccm
fusion
includ
mitochondri
exchang
essenti
somat
reprogram
understand
cellcel
fusion
conjunct
mitochondri
preserv
may
provid
altern
simpl
direct
mechan
rescu
cell
follow
ischemiainduc
damag
evid
indic
fusion
product
prolif
capac
regul
stem
cell
development
direct
dictat
somat
cell
combin
outcom
present
herein
mean
repopul
myocardium
function
improv
util
vmsc
understand
exploit
physiolog
role
msccm
fusion
induct
fusion
anoth
stem
cell
progenitor
even
matur
cell
type
may
augment
abil
repopul
repair
damag
myocardium
case
matur
progenitor
cell
transplant
induct
fusion
may
less
benefici
differenti
standpoint
benefici
engraft
retent
standpoint
one
primari
challeng
stem
cell
deliveri
cell
loss
transplant
prompt
develop
new
method
deliv
maintain
cell
heart
particularli
problemat
cardiac
therapi
heart
mechan
activ
rapidli
flush
cell
intend
target
region
stem
cell
transient
express
viral
fusogen
might
rapidli
adher
maintain
long
term
heart
ad
advantag
ph
sensit
fusogen
vsvg
abil
control
activ
cell
fuse
ph
lower
major
implic
induc
tempor
window
ischemia
spatial
ischem
region
regul
fusion
vivo
fact
vmsc
deliv
heart
found
patch
damag
myocardium
fuse
mous
cell
abil
vsvg
induc
fusion
patch
may
due
close
proxim
ischem
region
caus
environ
acid
remodel
collagen
patch
collagen
remodel
shown
occur
via
msc
secret
matrix
metalloproteinas
matrixin
serin
proteas
cystein
proteas
matrixin
activ
neutral
ph
serin
cystein
proteas
activ
acid
ph
indirectli
demonstr
cell
abl
make
microenviron
acid
taken
togeth
induct
cell
fusion
heart
could
exert
function
benefit
via
multipl
mechan
primari
limit
approach
introduc
viral
machineri
alreadi
damag
recipi
entir
virion
vsv
known
immunogen
high
enough
concentr
lethal
mice
purifi
vsvg
vsvg
reconstitut
lipid
bilay
administ
vitro
cell
cultur
mitogen
interestingli
lipid
concentr
increas
vsvg
concentr
held
constant
mitogen
decreas
suggest
space
vsvg
membran
play
role
confirm
import
vsvg
arrang
ochsenbein
et
al
demonstr
time
antibodi
produc
mice
highli
organ
vsvg
nucleocapsid
intact
vsv
versu
poorli
organ
vsvg
micel
amount
viral
protein
deliv
base
mass
protein
protein
express
per
cell
combin
number
cell
deliv
order
magnitud
report
amount
elicit
immun
respons
express
fusogen
entir
virion
even
method
develop
increas
express
level
per
cell
andor
combin
high
number
cell
space
could
evalu
avoid
immun
respons
howev
base
report
concentr
requir
elicit
respons
deliveri
vmsc
prepar
studi
would
trigger
respons
vmsc
may
immunogen
transfect
may
caus
advers
genet
effect
instanc
stabl
transfect
viral
system
caus
integr
gene
random
site
genom
mutagenesi
occur
integr
may
occur
site
interfer
cell
abil
regul
result
deregul
prolifer
tumorigenesi
addit
experiment
evid
malign
seen
clinic
review
transfect
larg
transient
rare
integr
genom
clinic
use
would
requir
safeguard
perhap
includ
liposom
deliveri
protein
data
present
support
util
vsvgmediat
fusion
studi
effect
stem
cell
fusion
cell
reprogram
function
improv
tissu
includ
heart
futur
studi
may
also
employ
vsvg
rescu
damag
cell
ischem
tissu
bodi
even
select
target
cell
destruct
exampl
microenviron
tumor
overact
osteoclast
paget
diseas
ph
threshold
necessari
activ
conform
chang
vsvg
local
administr
vsvg
liposom
contain
toxic
factor
highli
acid
ph
microenviron
may
fuse
poorli
regul
cell
dampen
detriment
effect
